As reported in the Journal of Clinical Oncology by Charles A. Schiffer, MD, of Karmanos Cancer Institute, Wayne State University School of Medicine, and colleagues, ASCO has issued a clinical practice guideline update on platelet transfusions in patients with cancer.
The updated guideline replaces the former guideline, initially issued in 2001. The updated guideline is informed by an ASCO expert panel systematic review of literature published from September 2014 through October 2016, two 2015 systematic reviews conducted by the AABB (formerly, the American Association of Blood Banks) and the International Collaboration for Transfusion Medicine Guidelines, and an ASCO literature search back to 2000 for issues not covered in the 2015 reviews. Overall, the updated ASCO review included 24 more recent publications, including 3 clinical practice guidelines, 8 systematic reviews, and 13 observational studies. The expert panel was co-chaired by Dr. Schiffer and Kenneth C. Anderson, MD, of Dana-Farber Cancer Institute, Harvard Medical School.
Key elements of the updated recommendations are summarized here.
Key Elements of Updated Recommendations
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.